- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02782234
Application Contract Management Mode in Maintaining PD Fluid Balance (ACMMPDFB)
Application of Contract Management Mode in Maintaining Body Fluid Balance of Peritoneal Dialysis Patients
Contract management is a new management mode.
To help patients achieve fluid balance through contract management, that is:
- edema, congestive heart failure and other similar symptoms begin to reduce to disappear;
- Blood pressure control in normal range, that is 90-140/60-90mmHg, or the target value prescribed by the doctors;
- Fluid intake and output keep in balance;
- No imbalance symptoms turn out, such as edema, congestive heart failure, etc.
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Contract management is a new management mode, it stipulate and constraint various relationship by various duties, institutions and regulations.
To help patients achieve fluid balance through contract management, that is:
- edema, congestive heart failure and other similar symptoms begin to reduce to disappear;
- Blood pressure control in normal range, that is 90-140/60-90mmHg, or the target value prescribed by the doctors;
- Fluid intake and output keep in balance;
- No imbalance symptoms turn out, such as edema, congestive heart failure, etc.
In addition to help keeping the fluid balance through contract balance, but also:
- Improve compliance;
- Improve the patients' cognition of fluid balance;
- Improve the ability of self-management of fluid balance.
Study Type
Enrollment (Anticipated)
Phase
- Not Applicable
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Older or equal to 18 years, younger or equal to 65 years, CAPD duration over 6 months
- Edema or congestive heart failure happen
- Patients with poor control of blood pressure, that is less than 90/60mmHg,or over 140/90mmHg, or the Bp does not meet the value given by doctors
- Patients with fluid imbalance of intake and output.
Exclusion Criteria:
- Younger than 18, or older than 65, or CAPD period less than 6 months
- The primary disease is high blood pressure, or edema due to low protein
- Patients that lost control of daily life
- Malignant tumor or pregnancy
- Falling in Chronic infection or severe complication within 1 month, such as hepatic disease, hemorrhage of digestive tract, etc.
- Patients with cognition impairment, conscious disorder, or mental disease.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Health Services Research
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
No Intervention: not contract management
monthly follow-up phone or family visit completed as regulation, and instruct them proper healthy training.
|
|
|
Experimental: Contract management
In accordance with the contract content, researchers and participants should manage and maintain the liquid balance of the participants.
Signed doctors and nurses should undergo the follow-up phone or family visit on time, instruct them proper healthy training, and provided necessary information data.
By telephone, SMS, wechat, remind and urge the participants to take the lifestyle and behavior regulate in the contract.
Participants should supervise and manage the fluid unbalance (Edema, hypertension, heart failure, and fluid imbalance of intake and output etc.), and feedback the Management and supervision to researchers according to contract.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Volume of fluid intake and output keep in balance measured in ml.
Time Frame: 24 hours
|
as the physiological parameter for this Outcome.
Volume measurement unit should be used in pd subjects, the unit ml.
|
24 hours
|
|
Change in Blood Pressure
Time Frame: two times a day, through study completion, an average of 6 months. changed from baseline
|
two times a day, blood pressure measure at a.m.6∶0 0~ 8∶0 0 ,p.m.15∶0 0~ 18∶0 0. The subjects for the first time measuring blood pressure for the baseline.
|
two times a day, through study completion, an average of 6 months. changed from baseline
|
|
Change in weight
Time Frame: once a day, through study completion, an average of 6 months. changed from baseline
|
The subjects for the first time measuring weight for the baseline measured in kg.
|
once a day, through study completion, an average of 6 months. changed from baseline
|
Collaborators and Investigators
Study record dates
Study Major Dates
Study Start
Primary Completion (Anticipated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Estimate)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Other Study ID Numbers
- 2 ndharbinmu
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Contract Management PD
-
University of North Texas, Denton, TXThe University of Texas Health Science Center at San AntonioRecruitingContingency Management | Alcohol Abuse | Alcohol Intervention | Transdermal Alcohol Monitoring | Deposit ContractUnited States
-
Tianjin Medical UniversityTianjin Medical University General HospitalRecruitingPD-L1 Gene Mutation | Positron Emission Tomography | PD-L1 Gene Amplification | PD-L1-related DiseaseChina
-
Oxford Biodynamics Inc.Community Clinical Oncology Research Network, LLCRecruitingCancer | Immunotherapy | PD-L1 | PD-1 | Immune Checkpoint TherapyUnited States
-
Shanghai Xinzhi BioMed Co., Ltd.Recruiting
-
Samsung Medical CenterUnknown
-
Sohag UniversityRecruitingContract Induced NephropathyEgypt
-
Agenus Inc.CompletedAdvanced Solid Cancers | Advanced Solid Cancers Refractory to PD-1 and PD-L1 TherapiesUnited States
-
Dr. Mehak NaeemUniversity of Health Sciences LahoreRecruiting
-
Aida Frías GonzálezSpanish Society of Nephrology; SOMANE (MADRID SOCIETY OF NEPHROLOGY); Foundation...RecruitingPeritoneal Dialysis (PD)Spain
-
EicOsis Human Health Inc.University of California, Davis; Michael J. Fox Foundation for Parkinson's...RecruitingParkinson's Disease (PD)United States
Clinical Trials on Contract management
-
University of California, BerkeleyEunice Kennedy Shriver National Institute of Child Health and Human Development... and other collaboratorsCompleted
-
WayBetter, Inc.Hennepin Healthcare Research InstituteCompletedSmoking CessationUnited States
-
University of CopenhagenElsass FoundationRecruiting
-
National Bureau of Economic Research, Inc.Northwestern UniversitySuspendedSmoking Cessation | Weight LossUnited States
-
University of PennsylvaniaHarvard University; Carnegie Mellon University; incentaHEALTH; McKinsey & CompanyCompleted
-
University of LahoreCompleted
-
Wills EyeJohns Hopkins University; University of Miami; University of Alabama at Birmingham and other collaboratorsCompletedDiabetes Mellitus | Diabetic RetinopathyUnited States
-
Community Health Center, Inc.Yale University; Innovations for Poverty ActionCompleted
-
Assistance Publique - Hôpitaux de ParisUnknown
-
Universidade Federal de PernambucoCompletedMigraine DisordersBrazil